1 completed, 1 terminated, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Fertility: new trials by email Literature Review of Fertility trials Research Report on Fertility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin Desogestrel and ethinylestradiol fixed dose combination, Follitropin alfa/lutropin alfa - Fertility | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 24 | 2025-11-24 | 2026-03-18 |
| A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump Lutrepulse - Amenorrhea, Fertility | Phase 1 | Withdrawn | Ferring Pharmaceuticals | 2025-09-12 | 2025-11-14 | |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation Follitropin delta, FE999302, FE999302 Placebo - Fertility | Phase 1 | Terminated | Ferring Pharmaceuticals | 310 | 2024-06-14 | 2026-03-30 |
Infertility (2) · Amenorrhea (1)
Genital Diseases (2) · Urogenital Diseases (2) · Menstruation Disturbances (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Desogestrel (1) · Ethinyl Estradiol (1) · Gonadotropin-Releasing Hormone (1) · follitropin delta (1) · pergoveris (1)
Ferring Pharmaceuticals (2) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)
Belgium (1) · Czechia (1) · Denmark (1) · Norway (1) · Spain (1) · United Kingdom (1) · United States (1)
2023 (1)